Brief: Brickell Biotech Inc - Kaken Plans To Launch ECCLOCK For Treatment Of Primary Axillary Hyperhidrosis In Japan On November 26, 2020

Fresh Tracks Therapeutics

18/11/2020 12:12

Nov 18 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH INC - KAKEN PLANS TO LAUNCH ECCLOCK FOR
TREATMENT OF PRIMARY AXILLARY HYPERHIDROSIS IN JAPAN ON NOVEMBER
26, 2020
    * BRICKELL BIOTECH INC - ECCLOCK PLACED ON JAPAN'S NATIONAL
HEALTH
INSURANCE DRUG REIMBURSEMENT PRICE LIST
    * BRICKELL BIOTECH INC - NHI LISTED DRUG PRICE FOR ECCLOCK
IN
JAPAN IS ¥243.70 PER GRAM, WHICH IS ¥4,874.00 FOR A 20 GRAM
BOTTLE

Source text for Eikon:  ID:nGNX90q0zG 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))